비교리스트

 카트 문의
시장보고서
상품코드
1654336

색전 방지 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2025-2030년)

Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Proximal Occlusion Systems, Distal Occlusion Systems, Distal Filters), By Application, By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

색전 방지 기기 시장 성장과 동향:

세계 색전 방지 기기 시장 규모는 2030년 11억 달러에 달할 것으로 예상되며, 2025년부터 2030년까지 연평균 8.9%의 성장률을 보일 것으로 예상됩니다. 심혈관질환 및 신경혈관 질환의 증가, 최소침습적 질환의 채택 확대가 시장 성장을 견인하고 있습니다. 기술적으로 진보된 색전술 기기에 대한 수요 증가와 의료비 지출 증가는 다국적 기업의 막대한 자금 지원과 투자로 이어져 세계 의료기기 산업의 연구개발에 박차를 가하고 있습니다. 이러한 요인도 시장 성장에 기여하고 있습니다.

반면, 제품 결함이나 리콜이 시장 성장을 제한할 가능성도 있습니다. 또한, 스텐트 치료에 대한 낮은 급여 수준과 약제 사용 등 대체 치료법의 존재도 시장 개척에 걸림돌이 될 수 있습니다. 그러나 경피적 대동맥판막치환술(TAVR) 건수 증가 등의 요인은 시장 확대를 뒷받침할 것으로 보입니다.

색전 방지 기기 시장 : 분석 개요

  • 원위부 필터는 중재 시술 중 색전증에 대한 효율적인 보호 기능을 제공함으로써 2024년 48.0%의 가장 큰 점유율을 차지했습니다.
  • 심혈관질환은 2024년 43.1%로 가장 높은 수익 점유율을 차지했습니다.
  • 신경혈관 질환은 예측 기간 동안 연평균 7.9%의 성장률을 보일 것으로 예상됩니다.
  • 최소침습 수술에 대한 선호도가 높아지면서 시장 역학이 더욱 강화되고 있습니다.
  • 북미 색전 방지 기기 시장은 2024년 29.1%의 매출 점유율로 세계 시장을 장악했습니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 색전 방지 기기 시장 : 변수, 동향, 범위

  • 시장 연관 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 비즈니스 환경 분석
    • 업계 분석 : Porter's Five Forces 분석
    • PESTEL 분석

제4장 색전 방지 기기 시장 : 제품별 비즈니스 분석

  • 시장 점유율 : 제품별(2024년·2030년)
  • 제품별 대시보드
  • 시장 규모 예측과 동향 분석 : 제품별(2018-2030년)
  • 근위 폐색 시스템
  • 원위 폐색 시스템
  • 원위 필터

제5장 색전 방지 기기 시장 : 용도별 비즈니스 분석

  • 시장 점유율 : 용도별(2024년·2030년)
  • 용도별 대시보드
  • 시장 규모 예측과 동향 분석 : 용도별(2018-2030년)
  • 심혈관 질환
  • 신경혈관 질환
  • 말초 질환

제6장 색전 방지 기기 시장 : 지역별 추정·동향 분석

  • 시장 점유율 : 지역별(2024년·2030년)
  • 지역별 대시보드
  • 시장 규모 예측과 동향 분석 : 지역별(2018-2030년)
  • 북미
    • 국가별(2018-2030년)
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 국가별(2018-2030년)
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 덴마크
    • 스웨덴
  • 아시아태평양
    • 국가별(2018-2030년)
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 국가별(2018-2030년)
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 국가별(2018-2030년)
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제7장 경쟁 구도

  • 시장 진출 기업 개요
  • 기업의 시장 포지션 분석
  • 기업 분류
  • 전략 매핑
  • 기업 개요/상장 기업
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Abbott
    • Medtronic
    • Cardinal Health
    • Innovative Cardiovascular Solutions, LLC
    • Transverse Medical Inc.
    • WL Gore &Associates, Inc.
ksm 25.03.17

Embolic Protection Devices Market Growth & Trends:

The global embolic protection devices market size is expected to reach USD 1.1 billion in 2030 and is projected to grow at a CAGR of 8.9% from 2025 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.

Embolic Protection Devices Market Report Highlights:

  • Distal filters accounted for the largest share of 48.0% in 2024 due to their ability to offer efficient protection against embolization during interventional procedures
  • Cardiovascular diseases held the highest revenue share of 43.1% in 2024
  • Neurovascular diseases are projected to grow at a CAGR of 7.9% over the forecast period
  • The growing preference for minimally invasive surgical techniques has further bolstered market dynamics.
  • North America embolic protection devices market dominated the global market with a revenue share of 29.1% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Embolic Protection Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Embolic Protection Devices Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Proximal Occlusion Systems
    • 4.4.1. Proximal Occlusion Systems Market, 2018 - 2030 (USD Million)
  • 4.5. Distal Occlusion Systems
    • 4.5.1. Distal Occlusion Systems Market, 2018 - 2030 (USD Million)
  • 4.6. Distal Filters
    • 4.6.1. Distal Filters Market, 2018 - 2030 (USD Million)

Chapter 5. Embolic Protection Devices Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
  • 5.5. Neurovascular Diseases
    • 5.5.1. Neurovascular Diseases Market, 2018 - 2030 (USD Million)
  • 5.6. Peripheral Diseases
    • 5.6.1. Peripheral Diseases Market, 2018 - 2030 (USD Million)

Chapter 6. Embolic Protection Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Boston Scientific Corporation
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Edwards Lifesciences Corporation
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Abbott
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Medtronic
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Cardinal Health
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Innovative Cardiovascular Solutions, LLC
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Transverse Medical Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. W. L. Gore & Associates, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제